Comparison of Erector Spina Plan Block and Trnsversus Abdominis Plan Block in Laparoscopic Nephrectomy: Prospective Randomized Clinical Trial

Laparoscopic Nephrectomy Clinical Trial

Official title:

Comparison of Erector Spina and Transversus Abdominus Plan Blocks

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT05913167
• Other study ID #: LAPNEF2023
• Status: Recruiting
• Phase: N/A
• Start date: August 15, 2023
• Est. completion date: June 15, 2025

Study information

• Verified date: December 2023
• Source: Kocaeli University
• Contact: Zehra Arslan
• Phone: 0090303
• Email: zehraipekarslan[@]hotmail.com
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Nephrectomy pain was higher. erector spina plan block and transversus abdominis plan block had shown to be effective in abdominal surgeries. This study aimed to compare these two bloc analgesic efficacy in laparoscopic nephrectomy patients. The primary aim is postoperative morphine consumption.

Description:

Patients ASA 18-65 who will undergo laparoscopic nephrectomy are included in this prospective randomized clinical trial. Patients will be divided into two groups; erector spina and transversus abdominis plane block. Anesthesia will. induced with propofol, fentanyl, and rocuronium will be administered for muscle relaxation. Bispectral index monitoring will be used for monitorisation of the depth of anesthesia. Remifentanil was used during the whole procedure. the amount of consumption will be recorded. Patient-controlled device will be used with morphine. The postoperative morphine consumption will also be recorded.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 50
• Est. completion date: June 15, 2025
• Est. primary completion date: June 15, 2025
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 65 Years

Eligibility

Inclusion Criteria:

• 18-65 age

• patients undergoing laparoscopic nephrectomy

• ASA 1-3

Exclusion Criteria:

• <18- >65 < age

• patients undergoing open nephrectomy

• ASA 4-5

Related Conditions & MeSH terms

• Laparoscopic Nephrectomy

Intervention

Procedure:
• laparoscopic nephrectomy
laparoscopic nephrectomy

Locations

Country	Name	City	State
Turkey	Kocaeli University	Kocaeli

Sponsors (1)

Lead Sponsor	Collaborator
Kocaeli University

Country where clinical trial is conducted

Turkey, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Postoperative morphine consumption	morphine patient controlled analgesia was applied to the patients	24 hour postoperatively
Secondary	Peroperative remifentanil consumptions	continious remifentanil infusion was applied	peroperatively
Secondary	postoperative analgesia numeric rating scales	patients will give numbers to their pain first hour, 6th hour and 24 th hour after surgery	postoperative 24 hours